Target intelligence / Profile preview

CTDSPL2 pseudogene 2 (CTDSPL2P2)

Target
CTDSPL2P2
Molecular classification
Other (Pseudogene)
01

Overview

CTDSPL2 pseudogene 2 (CTDSPL2P2) is classified as a pseudogene in the human genome and does not encode a functional protein[6][7]. Pseudogenes are segments of DNA that resemble known genes but are typically nonfunctional due to mutations such as frameshifts or premature stop codons. CTDSPL2P2 is related in sequence to the functional gene CTDSPL2, which encodes a protein with RNA polymerase II CTD heptapeptide repeat phosphatase activity involved in the regulation of transcription by RNA polymerase II[1][4]. However, as a pseudogene, CTDSPL2P2 lacks documented biological function, molecular activity, or clinical relevance[6][7]. There are no approved drugs, disease associations, or biomarker roles associated with CTDSPL2P2, and it is not considered a drug discovery or therapeutic target. Additional context: - The reference gene, CTDSPL2, is a catalytic phosphatase involved in transcriptional regulation, but CTDSPL2P2 is not known to encode a similar active product[1][4][6]. - Pseudogenes like CTDSPL2P2 are important in evolutionary biology and genomics, sometimes modulating expression of their functional counterparts via non-coding RNA mechanisms, but there is no specific evidence for such a function for CTDSPL2P2[3]. Summary: CTDSPL2P2 is a pseudogene, not a therapeutic or biologically active target, and should not be used or referenced as a target for drug development or biomarker purposes[6][7].

Other names
CTDSPL2P2[6][7]CTDSPL2 pseudogene 2[6][7]

Beyond the preview

Go deeper on CTDSPL2 pseudogene 2 (CTDSPL2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CTDSPL2 pseudogene 2 (CTDSPL2P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call